Predictors of Booster Response to Hepatitis B Vaccine at 15 years of age: A Cross-Sectional School-Based Study

Pediatrics and Neonatology

Volumn 57, Issue 4, 2016, Pages 302-309

  Chen, Yu Sheng ^a   Chu, Chia Hsiang ^a   Wang, Jen Hung ^a   Lin, Jun Song ^a   Chang, Yung Chieh ^a  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

adolescents; anamnestic response; HBV booster; infant HBV vaccination

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B ANTIBODY;

ADAPTIVE IMMUNITY; ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HEALTH CARE SURVEY; HEPATITIS B; HIGH SCHOOL STUDENT; HUMAN; LIVER FUNCTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SEROEPIDEMIOLOGY; SEROLOGY; SEX DIFFERENCE; TREATMENT RESPONSE; VACCINATION; BLOOD; SECONDARY IMMUNIZATION;

ADOLESCENT; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION, SECONDARY; MALE; SEROEPIDEMIOLOGIC STUDIES;

EID: 84951994335     PISSN: 18759572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pedneo.2015.09.006     Document Type: Article

References (18)

1. 1 Chen, H.L., Chang, M.H., Ni, Y.H., Hsu, H.Y., Lee, P.I., Lee, C.Y., et al. Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan. JAMA 276 (1996), 906–908.
2. 2 Ni, Y.H., Chen, D.S., Hepatitis B vaccination in children: the Taiwan experience. Pathol Biol (Paris) 58 (2010), 296–300.
3. 3 Jack, A.D., Hall, A.J., Maine, N., Mendy, M., Whittle, H.C., What level of hepatitis B antibody is protective?. J Infect Dis 179 (1999), 489–492.
4. 4 Plotkin, S., Orenstein, W., Offit, P., Vaccines. 2013, Elsevier, Philadelphia, 205–234.
5. 5 Chien, Y.C., Jan, C.F., Kuo, H.S., Chen, C.J., Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched. Epidemiol Rev 28 (2006), 126–135.
6. 6 Ni, Y.H., Huang, L.M., Chang, M.H., Yen, C.J., Lu, C.Y., You, S.L., et al. Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategies. Gastroenterology 132 (2007), 1287–1293.
7. 7 Are booster immunisations needed for lifelong hepatitis B immunity?, European Consensus Group on Hepatitis B Immunity. Lancet 355 (2000), 561–565.
8. 8 Chang, Y.C., Wang, J.H., Chen, Y.S., Lin, J.S., Cheng, C.F., Chu, C.H., Hepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study. BMC Public Health, 14, 2014, 991.
9. 9 Lee, P.I., Lee, C.Y., Huang, L.M., Chang, M.H., Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigen. J Pediatr 126 (1995), 716–721.
10. 10 Lin, Y.C., Chang, M.H., Ni, Y.H., Hsu, H.Y., Chen, D.S., Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan. J Infect Dis 187 (2003), 134–138.
11. 11 Lin, C.C., Yang, C.Y., Shih, C.T., Chen, B.H., Huang, Y.L., Waning immunity and booster responses in nursing and medical technology students who had received plasma-derived or recombinant hepatitis B vaccine during infancy. Am J Infect Control 39 (2011), 408–414.
12. 12 Koff, R.S., Immunogenicity of hepatitis B vaccines: implications of immune memory. Vaccine 20 (2002), 3695–3701.
13. 13 Jan, C.F., Huang, K.C., Chien, Y.C., Greydanus, D.E., Davies, H.D., Chiu, T.Y., et al. Determination of immune memory to hepatitis B vaccination through early booster response in college students. Hepatology 51 (2010), 1547–1554.
14. 14 Girón-González, J.A., Moral, F.J., Elvira, J., García-Gil, D., Guerrero, F., Gavilán, I., et al. Consistent production of a higher TH1:TH2 cytokine ratio by stimulated T cells in men compared with women. Eur J Endocrinol 143 (2000), 31–36.
15. 15 McMurray, R.W., Ndebele, K., Hardy, K.J., Jenkins, J.K., 17-beta-estradiol suppresses IL-2 and IL-2 receptor. Cytokine 14 (2001), 324–333.
16. 16 Dentico, P., Buongiorno, R., Volpe, A., Zavoianni, A., Pastore, G., Schiraldi, O., Long-term immunogenicity safety and efficacy of a recombinant hepatitis B vaccine in healthy adults. Eur J Epidemiol 8 (1992), 650–655.
17. 17 Fang, J.W., Lai, C.L., Chung, H.T., Wu, P.C., Lau, J.Y., Female children respond to recombinant hepatitis B vaccine with a higher titre than male. J Trop Pediatr 40 (1994), 104–107.
18. 18 Chen, C.C., Yen, C.H., Wu, W.Y., Hu, S.W., Chen, S.C., Bell, W.R., et al. Epidemiology of hepatitis B virus infection among young adults in Taiwan, China after public vaccination program. Chin Med J (Engl) 120 (2007), 1155–1158.